Mantzarlis, K.; Vazgiourakis, V.; Papadopoulos, D.; Valsamaki, A.; Xitsas, S.; Tanaka, M.; Chovas, A.; Manoulakas, E.
Treatment Options for Critically Ill Patients with Infections Caused by Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae. Antibiotics 2025, 14, 1156.
https://doi.org/10.3390/antibiotics14111156
AMA Style
Mantzarlis K, Vazgiourakis V, Papadopoulos D, Valsamaki A, Xitsas S, Tanaka M, Chovas A, Manoulakas E.
Treatment Options for Critically Ill Patients with Infections Caused by Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae. Antibiotics. 2025; 14(11):1156.
https://doi.org/10.3390/antibiotics14111156
Chicago/Turabian Style
Mantzarlis, Konstantinos, Vassilios Vazgiourakis, Dimitrios Papadopoulos, Asimina Valsamaki, Stelios Xitsas, Masumi Tanaka, Achilleas Chovas, and Efstratios Manoulakas.
2025. "Treatment Options for Critically Ill Patients with Infections Caused by Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae" Antibiotics 14, no. 11: 1156.
https://doi.org/10.3390/antibiotics14111156
APA Style
Mantzarlis, K., Vazgiourakis, V., Papadopoulos, D., Valsamaki, A., Xitsas, S., Tanaka, M., Chovas, A., & Manoulakas, E.
(2025). Treatment Options for Critically Ill Patients with Infections Caused by Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae. Antibiotics, 14(11), 1156.
https://doi.org/10.3390/antibiotics14111156
